Quick Answer
ACCENDRA HEALTH INC/VA/ reported Cash and Equivalents of $281.99 million for fiscal year 2025.
ACCENDRA HEALTH INC/VA/ Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $281.99M | +922.7% |
| 2024 | $27.57M | -88.7% |
| 2023 | $243.04M | +249.9% |
| 2022 | $69.47M | +24.7% |
| 2021 | $55.71M | -32.9% |
| 2020 | $83.06M | +23.9% |
| 2019 | $67.03M | +1.1% |
| 2018 | $66.31M | -36.6% |
| 2017 | $104.52M | -43.7% |
| 2016 | $185.49M | +15.2% |
| 2015 | $161.02M | +183.6% |
| 2014 | $56.77M | -44.3% |
| 2013 | $101.91M | +4.1% |
| 2012 | $97.89M | -28.0% |
| 2011 | $135.94M | -14.6% |
| 2010 | $159.21M | +65.6% |
| 2009 | $96.14M | +1119.1% |
| 2008 | $7.89M | -24.1% |
| 2007 | $10.39M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $32.84M | -27.8% | -14.2% |
| June 30, 2025 | $38.26M | -84.3% | -35.6% |
| March 31, 2025 | $59.44M | -75.7% | +115.6% |
| December 31, 2024 | $27.57M | -88.7% | -39.3% |
| September 30, 2024 | $45.45M | -78.9% | -81.3% |
| June 30, 2024 | $243.67M | -14.9% | -0.5% |
| March 31, 2024 | $244.87M | +266.3% | +0.8% |
| December 31, 2023 | $243.04M | +249.9% | +12.9% |
- ACCENDRA HEALTH INC/VA/ showed an increase of +922.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2007–2025 period, ACCENDRA HEALTH INC/VA/’s cash and equivalents has grown by 2612.7% (from $10.39 million to $281.99 million).
- The most recent figure is from ACCENDRA HEALTH INC/VA/’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: